During the past decade, cotton prices remained considerably below other agricultural prices (although they recovered toward the end of 2010). Yet, between 2000-04 and 2005-09 world cotton production increased 13 percent. This paper conjectures that biotechnology-induced productivity improvements...

This Article reveals that many already issued and actively enforced medical biotechnology patents may be invalid. Biologics, medical therapeutics derived through biotechnology techniques, are the fastest growing and most promising pharmaceutical sector. They represent a $45 billion a year...

Drawing on semi-structured interviews carried out with founders, managers, and senior scientists in start-up biotech firms, this paper illustrates that the socio-legal literature's characterization of small firms as less compliance oriented is too neat. Small firms do not necessarily have a...

Technological innovation in agriculture can bring enormous benefits to the poor. High-yielding varieties of staple food crops have improved agricultural productivity, raised incomes, and reduced food prices. Innovations in plant breeding research based on advances in genetics that make it...

Increases in alliance activity between research-intensive firms and incumbents is puzzling since it is challenging to contract upon highly uncertain R&D activities. Our paper extends prior research by exploring the relationship between firm capabilities and preferences for control rights. This...

This paper explores how and why collaboration with different types of partners and the position within a research network can affect firms' innovative performance in terms of product innovations. A detailed empirical analysis is carried out in the biotechnology and pharmaceutical industry. This...

The increasing use of assisted reproductive technologies, such as in vitro fertilization, raises new and complex legal issues of parentage and inheritance. This Article examines the various reasons people use assisted reproductive technologies, issues that have arisen due to the use of these...

Biotechnology has ushered in both profound and mundane innovations, and it has presented accompanying challenges for a variety of legal institutions, but the academic literature on this subject is littered with superficial and overly alarmist work. Among other things, this Article selects for an...

The view that biotechnology patenting has reached unsustainable levels is well accepted among many legal scholars. This Article presents the first comprehensive empirical study of biotechnology patents. Our analysis reveals the striking rise and fall in patenting, the surprisingly diffuse...

Scientist-entrepreneurs prominent in biotech and other high-technology industries view going public not as a cost-effective source of capital but as a cross between selling a now-proven innovation and winning a lottery. Unlike most empirical IPO analyses confined to those firms that go public,...